Company intelligence / Profile preview

湖北多瑞药业

Jingzhou, Hubei, China
Ownership
Private
Employees
~150
Development stage
Other
01

Overview

Hubei Duorui Pharmaceutical Co., Ltd. is a Chinese pharmaceutical manufacturing company founded in 2005 and based in Jingzhou, Hubei Province. The company specializes in the research, development, and large-scale production of therapeutic infusions, small molecule formulations, and contract manufacturing (CMO/CDMO) services. Its commercial portfolio includes key products such as Sodium Acetate Ringer's Injection, Venlafaxine Hydrochloride Extended-Release Capsules, Amisulpride Injection, and Tranexamic Acid Injection, targeting therapeutic areas like anesthesia, psychiatry, and anti-infectives. In August 2026, its parent company, Tibet Duorui Pharmaceutical, announced the divestment of 100% of Hubei Duorui's equity to Tibet Jiakang Shidai Technology Development for approximately 77.26 million RMB to optimize its business structure.

Therapeutic areas
PsychiatryGastroenterologyInfectious DiseasesNeurologyHematologyMetabolic Disorders
Modalities
Small molecule
Industry
Pharma
02

Partnerships

Beijing Pudekangli Pharmaceutical Technology Development

Beyond the preview

Go deeper on 湖北多瑞药业.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 湖北多瑞药业.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call